VB
Vikas Bhardwaj
Medical Technologist, AIIMS New Delhi
Updated: Apr 17, 2026
**Core Concept**
The underlying principle being tested is the understanding of coagulation pathways, specifically the intrinsic pathway, and the factors involved. **Coagulation factor assays** and their interpretation are crucial in diagnosing bleeding disorders.
**Why the Correct Answer is Right**
The correct answer is related to the presence of an increased **activated partial thromboplastin time (aPTT)** with normal **prothrombin time (PT)** and platelet count, suggesting a problem in the intrinsic coagulation pathway. Given that **factor VIII levels** are within a relatively normal range (60 iu/ml), the issue is not with factor VIII deficiency.
**Why Each Wrong Option is Incorrect**
**Option A:** Factor IX deficiency would indeed increase aPTT but typically presents with bleeding symptoms, especially if severe. **Option B:** Thalassemia is a genetic disorder affecting hemoglobin production, not directly related to coagulation factor levels or aPTT. **Option C:** Factor VIII inhibitors would lead to decreased factor VIII activity, not compatible with the given level of 60 iu/ml.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that **lupus anticoagulant** can cause an increased aPTT without a significant bleeding history, due to its paradoxical effect of being a procoagulant in vivo despite its in vitro anticoagulant properties.
**Correct Answer:** d. Lupus anticoagulant